Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS)

NCT00676221 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Myfortic

Sponsor

Foothills Medical Centre

Collaborators

[object Object]